미래 지향적 PIPELINE 설계 창의적 제품 개발 및 최상의 품질 기준을 달성하겠습니다.
In 2012, DongKoo Bio&Pharma. has achieved Current Good Manufacturing Practice(CGMP), and constructed a safe and stable production system. We emphasize protection of our customers' rights operating a management program in terms of quality assurance and control, R&D, production and purchasing API.
Our main plant, Hyangnam factory, plays essential and sincere roles not only for exportation but domestic sales. The production base does its best in all aspects including the accumulation of technology and cost reduction in order to provide reliable medicines and medical products which contribute to public welfare.
A minor error may create an important difference in remedial effect and safety. DongKoo has produced high-quality medicines since 2012 strictly under the CGMP regulation. Besides, the CGMP regulation is applied to the whole production line from purchase of raw materials to packaging and shipment. The system enables us to check equalization of quality and contents. A close inspection and training of member of the production staffs are followed in order to operate the system.
We, DongKoo Bio&Pharma., make every effort to secure these factors through quality control by CGMP and exhaustive management system.Especially, high leveled analysis techniques and standardized inspection methods came from the latest test facilities such as HPLC and GC guarantee excellent quality of DongKoo’s products throughout the entire manufacturing process.In addition, DongKoo Bio&Pharma. supplies safe and reliable medicines and medical products which contribute to public welfare based on validation test and sanitary inspection of manufacturing process and facilities.